Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, USA.
Am J Psychiatry. 2013 Jan;170(1):94-101. doi: 10.1176/appi.ajp.2012.11121831.
The primary objective of this study was to determine whether contingency management was associated with increased abstinence from stimulant drug use in stimulant-dependent patients with serious mental illness treated in a community mental health center. Secondary objectives were to determine whether contingency management was associated with reductions in use of other substances, psychiatric symptoms, HIV risk behavior, and inpatient service utilization.
A randomized controlled design was used to compare outcomes of 176 outpatients with serious mental illness and stimulant dependence. Participants were randomly assigned to receive 3 months of contingency management for stimulant abstinence plus treatment as usual or treatment as usual with reinforcement for study participation only. Urine drug tests and self report, clinician-report, and service utilization outcomes were assessed during the 3-month treatment period and the 3-month follow-up period.
Although participants in the contingency management condition were significantly less likely to complete the treatment period than those assigned to the control condition (42% compared with 65%), they were 2.4 times (95% CI=1.9–3.0)more likely to submit a stimulant-negative urine test during treatment. Compared with participants in the control condition,they had significantly lower levels of alcohol use, injection drug use, and psychiatric symptoms and were one-fifth as likely as those assigned to the control condition to be admitted for psychiatric hospitalization during treatment. They also reported significantly fewer days of stimulant drug use during the 3-month follow-up.
When added to treatment as usual, contingency management is associated with large reductions in stimulant,injection drug, and alcohol use.Reductions in psychiatric symptoms and hospitalizations are important secondary benefits.
本研究的主要目的是确定在社区心理健康中心接受治疗的伴有严重精神疾病的兴奋剂依赖患者中,应急管理是否与兴奋剂使用戒除率的提高有关。次要目标是确定应急管理是否与其他物质使用减少、精神症状、艾滋病毒风险行为和住院服务利用率降低有关。
采用随机对照设计,比较了 176 名患有严重精神疾病和兴奋剂依赖的门诊患者的结果。参与者被随机分配接受 3 个月的兴奋剂戒除应急管理加常规治疗或仅接受研究参与强化的常规治疗。在 3 个月的治疗期间和 3 个月的随访期间评估尿液药物测试和自我报告、临床医生报告和服务利用结果。
尽管应急管理组的参与者在完成治疗期的可能性明显低于对照组(42%对 65%),但他们在治疗期间提交兴奋剂阴性尿液测试的可能性是对照组的 2.4 倍(95%CI=1.9–3.0)。与对照组相比,他们的酒精使用、注射毒品使用和精神症状水平显著较低,并且在治疗期间因精神科住院而入院的可能性是对照组的五分之一。他们在 3 个月的随访期间报告的兴奋剂使用天数也显著减少。
当添加到常规治疗中时,应急管理与兴奋剂、注射毒品和酒精使用的大量减少有关。精神症状和住院治疗的减少是重要的次要益处。